NCT03137758 2020-03-09A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerPellficure Pharmaceuticals, IncPhase 1 Terminated12 enrolled